Rezosicone CAS 1414777-24-4 MF C29H40O2 MW420.63 3β-(benzyloxy)-17-methylpregn-5-en-20-onecannabinoid CB1 receptor signalling inhibitor, S79V5L677D 1-[(3S,8R,9S,10R,13S,14S,17S)-10,13,17-trimethyl-3-phenylmethoxy-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone 1-((3S,8R,9S,10R,13S,14S,17S)-3-(benzyloxy)-10,13,17-trimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one Pregn-5-en-20-one, 17-methyl-3-(phenylmethoxy)-, (3β)- 3β-(benzyloxy)-17-methylpregn-5-en-20-one Rezosicone is a potent and selective cannabinoid CB1 receptor signaling inhibitor (or antagonist) primarily used in biochemical and pharmacology research Biological Mechanism Rezosicone selectively binds to and inhibits the CB1 receptor. CB1 receptors are heavily concentrated in … Continue reading Rezosicone